Interestingly, we observed a significant improvement in microbiological clearance among P2Y12 inhibitor users, which aligns with a case report describing successful clearance of bacteremia with ticagrelor administration in a patient with persistent bacteremia even after receiving proper antimicrobial treatment for S. aureus endovascular infection [9]. This evidence concerns the gene P2RY12 and bacterial infectious disease with sepsis.